These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 24853874)

  • 1. Case series describing an outbreak of highly resistant vancomycin Staphylococcus aureus (possible VISA/VRSA) infections in orthopedic related procedures in Guatemala.
    Antony SJ
    Infect Disord Drug Targets; 2014; 14(1):44-8. PubMed ID: 24853874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
    Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ
    J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteomyelitis with methicillin-resistant Staphylococcus aureus.
    Fitzpatrick DJ; Cafferkey MT; Toner M; Beattie T; Keane CT
    J Hosp Infect; 1986 Jul; 8(1):24-30. PubMed ID: 2875098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition and management of infections caused by vancomycin-intermediate Staphylococcus aureus (VISA) and heterogenous VISA (hVISA).
    Howden BP
    Intern Med J; 2005 Dec; 35 Suppl 2():S136-40. PubMed ID: 16271057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vancomycin intermediate and resistant Staphylococcus aureus. What the nephrologist needs to know.
    McDonald LC; Hageman JC
    Nephrol News Issues; 2004 Oct; 18(11):63-4, 66-7, 71-2 passim. PubMed ID: 15551615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India.
    Tiwari HK; Sen MR
    BMC Infect Dis; 2006 Oct; 6():156. PubMed ID: 17067393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus.
    Appelbaum PC
    Clin Microbiol Infect; 2006 Mar; 12 Suppl 1():16-23. PubMed ID: 16445720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative in vitro activities of dalbavancin and seven comparator agents against 41 Staphylococcus species cultured from osteomyelitis infections and 18 VISA and hVISA strains.
    Citron DM; Tyrrell KL; Goldstein EJ
    Diagn Microbiol Infect Dis; 2014 Aug; 79(4):438-40. PubMed ID: 24972854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful infection control for a vancomycin-intermediate Staphylococcus aureus outbreak in an advanced emergency medical service centre.
    Sakai Y; Qin L; Miura M; Masunaga K; Tanamachi C; Iwahashi J; Kida Y; Takasu O; Sakamoto T; Watanabe H
    J Hosp Infect; 2016 Apr; 92(4):385-91. PubMed ID: 26879881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Infectious spondylitis].
    Pintado-García V
    Enferm Infecc Microbiol Clin; 2008 Oct; 26(8):510-7. PubMed ID: 19094866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of vancomycin-intermediate and -resistant Staphylococcus aureus among methicillin-resistant S. aureus isolated from clinical specimens in the northwest of Iran.
    Ghahremani M; Jazani NH; Sharifi Y
    J Glob Antimicrob Resist; 2018 Sep; 14():4-9. PubMed ID: 29454049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Report-Isolation identification and control of vancomycin resistant Staphylococcus aureus.
    Liaqat F; Sheikh AA; Nazir J; Hussain T; Rabbani M; Shaheen AY; Muhammad J
    Pak J Pharm Sci; 2015 May; 28(3):997-1004. PubMed ID: 26004734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the first vancomycin intermediate-resistant Staphylococcus aureus (VISA) isolate from a hospital in Portugal.
    Gardete S; Aires-De-Sousa M; Faustino A; Ludovice AM; de Lencastre H
    Microb Drug Resist; 2008 Mar; 14(1):1-6. PubMed ID: 18346009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The microbiology of the infected knee arthroplasty.
    Nickinson RS; Board TN; Gambhir AK; Porter ML; Kay PR
    Int Orthop; 2010 Apr; 34(4):505-10. PubMed ID: 19458950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interdisciplinary management of infections with multidrug resistant Staphylococcus aureus strains].
    Fuchs M; Langer C; Schmid A
    Zentralbl Chir; 1996; 121 Suppl():76-8. PubMed ID: 8967250
    [No Abstract]   [Full Text] [Related]  

  • 16. Characterization of Infections with Vancomycin-Intermediate Staphylococcus aureus (VISA) and Staphylococcus aureus with Reduced Vancomycin Susceptibility in South Korea.
    Park JW; Lee H; Kim JW; Kim B
    Sci Rep; 2019 Apr; 9(1):6236. PubMed ID: 30996231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro susceptibilities and molecular analysis of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus isolates.
    Saravolatz LD; Pawlak J; Johnson LB
    Clin Infect Dis; 2012 Aug; 55(4):582-6. PubMed ID: 22615331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Characterization of Methicillin and Vancomycin Resistant
    Jahanshahi A; Zeighami H; Haghi F
    Microb Drug Resist; 2018 Dec; 24(10):1529-1536. PubMed ID: 29883257
    [No Abstract]   [Full Text] [Related]  

  • 19. Staphylococcus aureus resistant to vancomycin--United States, 2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Jul; 51(26):565-7. PubMed ID: 12139181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of vancomycin-resistant Staphylococcus aureus strains isolated from clinical samples: A three year study in Tehran, Iran.
    Shekarabi M; Hajikhani B; Salimi Chirani A; Fazeli M; Goudarzi M
    PLoS One; 2017; 12(8):e0183607. PubMed ID: 28854219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.